Study Confirms Risk of Bone Loss for Patients Taking ...

Breast cancer, exemestane (Aromasin®), tamoxifen (Nolvadex®), aromatase inhibitors, bone loss. (Definitions of many terms related to cancer can be found in the Cancer.gov Dictionary.)
Women who switched to the drug exemestane (Aromasin®) after ...
More Information

Leave a Comment:

(required)

(will not be published) (required)


Copyright © 1999-2012 Data Growth Pty Ltd. All rights reserved.
Privacy Policy | Terms of Use |